Abbott has been hit with a slew of complaints from the FDA in a warning letter related to its continuous glucose moni...
FDA issued a warning letter to Abbott citing multiple quality-system violations for its FreeStyle Libre continuous glucose monitor.
Why it mattersFDA warning letter over FreeStyle Libre quality violations requires investors and clinicians to re-evaluate procurement and risk controls.